Erasmus Bachus

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Scott D. Solomon, John J.V. McMurray, Brian Claggett et al. · New England Journal of Medicine · 2022 · 2.4K citations · Full text

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

Dapagliflozin for heart failure according to body mass index: the DELIVER trial

Carly Adamson, Toru Kondo, Pardeep S. Jhund et al. · European Heart Journal · 2022 · 140 citations · Full text

Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial

Jawad H. Butt, Pardeep S. Jhund, Jan Bělohlávek et al. · Circulation · 2022 · 138 citations · Full text

Cognitive Test Results are Associated with Mortality and Rehospitalization in Heart Failure: Swedish Prospective Cohort Study

Hannes Holm, Erasmus Bachus, Amra Jujić et al. · ESC Heart Failure · 2020 · 61 citations · Full text